Acute exacerbation of chronic maxillary sinusitis during therapy with nafarelin nasal spray
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Nafarelin nasal spray therapy was associated with the acute exacerbation of chronic maxillary sinusitis in a patient with a history of allergic rhinitis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (7)
- Adenomyosis: sonographic findings and diagnostic accuracy. via openalex
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures. via openalex
- Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex
- Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density via openalex
- Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
- W2001906671 via openalex
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:13.417725+00:00
- unpaywall
- last seen: 2026-06-15T06:18:04.506796+00:00
License: CC0
· commercial use OK